.Merck trumps incomes requirements, raises purchases outlook on sturdy need for best medicines like Keytruda CNBCMerck & Co. (MRK US) Beats Earnings Estimates as Keytruda Sales Surge BloombergMerck Inventory: Pharma Giant Posts Sturdy End Results, But Overview Drops Short Capitalist's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps earnings and also purchases expectations among Keytruda advantage, but offers combined full-year expectation MarketWatch.